HLA-DR matching defined by SSO-typing in heart transplantation.
Poli
F
F
Centro Trasfusionale e di Immunologia del Trapianti, Ospedale Maggiore, Milan, Italy.
Scalamogna
M
M
Pappalettera
M
M
Mascaretti
L
L
Nocco
A
A
Crespiatico
L
L
Sirchia
G
G
D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000401:mortality; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D015234:HLA-A Antigens / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology* / Q000401:mortality; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000379:methods*; D011183:Postoperative Complications / Q000276:immunology* / Q000401:mortality; D015996:Survival Rate
D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens; D016572:Cyclosporine